Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Oral Doses of JTT-252
Clinical trial NCT02120976 · TERMINATED
Trial details
- NCT number
- NCT02120976
- Sponsor
- Akros Pharma Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-01
- Primary completion
- 2015-02-01
- Enrollment
- 85
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.